Cargando…
Efficacy and safety of lenvatinib–transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond Up-to-7 criteria: a study protocol for a multicentre, single-arm, prospective study
INTRODUCTION: The feasibility and efficacy of surgical resection following systemic therapy for intermediate-stage hepatocellular carcinoma (HCC) beyond the Up-to-7 criteria is unclear. The combination of lenvatinib (LEN) and transcatheter arterial chemoembolisation (TACE), termed LEN–TACE sequentia...
Autores principales: | Oshita, Ko, Kobayashi, Tsuyoshi, Namba, Yosuke, Fukuhara, Sotaro, Matsubara, Keiso, Takei, Daisuke, Nakano, Ryosuke, Okamoto, Wataru, Sakai, Hiroshi, Tanimine, Naoki, Nakahara, Takashi, Kuroda, Shintaro, Tahara, Hiroyuki, Ohira, Masahiro, Kawaoka, Tomokazu, Ide, Kentaro, Imamura, Michio, Aikata, Hiroshi, Ohdan, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565137/ https://www.ncbi.nlm.nih.gov/pubmed/37798025 http://dx.doi.org/10.1136/bmjopen-2023-073797 |
Ejemplares similares
-
Preoperative percutaneous or transvascular marking for curative resection of small liver tumours with potential for missing during hepatectomy: a study protocol for an open-label, single-arm phase II study
por: Fukuhara, Sotaro, et al.
Publicado: (2023) -
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
por: Chen, Yen-Yang, et al.
Publicado: (2020) -
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
por: Kudo, Masatoshi, et al.
Publicado: (2020) -
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy
por: Ohya, Kazuki, et al.
Publicado: (2019) -
Multicentre, randomised, placebo-controlled trial of extract of Japanese herbal medicine Daikenchuto to prevent bowel dysfunction after adult liver transplantation (DKB 14 Study)
por: Kaido, Toshimi, et al.
Publicado: (2015)